Key clinical point: Patients with intermediate left main coronary disease (LMD) had worse outcomes than those without.
Major finding: The rate of cardiovascular events as a primary outcome was significantly higher among individuals with intermediate LMD (defined as 25%-49%) compared to those without (adjusted hazard ratio 1.31).
Study details: The data come from 3,699 adults in a sub-study of participants in the ISCHEMIA trial.
Disclosures: The study received no outside funding. The researchers had no financial conflicts to disclose.
Bangalore S et al. SCAI 2020 Scientific Sessions Virtual Conference. May 14-16, 2020. Abstract #11656.